Study finds promise in combined transplant/vaccine therapy for high-risk leukemia

Friday, August 28, 2009 - 23:58 in Health & Medicine

Two of the most powerful approaches to cancer treatment — a stem cell transplant and an immune system-stimulating vaccine — appear to reinforce each other in patients with an aggressive, hard-to-control form of leukemia, Harvard scientists at Dana-Farber Cancer Institute (DFCI) have found.read more

Read the whole article on Harvard Science

More from Harvard Science

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net